These alternative drugs, taken by hundreds of thousands, have from time to time been prescribed by health care professionals via telehealth businesses, boosting issues about an absence of continuity of treatment and a shift away from a patient’s Main care physician. (In recent months, the FDA has taken techniques to efficiently ban these copycat